Christian Meyer and Gisela Grabow discuss potential changes to the EU pharmaceutical regulation and their potential impact on data and market protection timelines for medicinal products
EU pharmaceutical reforms propose changes to regulatory protection periods, Managing IP 2024
To the publication
